Erythroderma in two patients with psoriasis upon discontinuation of efalizumab treatment

Author： Kop Else Korver John Van Ruysevelt Delphine De Jong Elke Van der Valk Pieter Van de Kerkhof Peter

ISSN： 1471-1753

Source： Journal of Dermatological Treatment, Vol.20, Iss.1, 2009-01, pp. : 67-69

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cytomegalovirus Complicating Biological Immunosuppressive Therapy in Two Patients with Psoriasis Receiving Treatment with Etanercept or Efalizumab

By Petersen Bibi Lorentzen Henrik

Acta Dermato-Venereologica, Vol. 88, Iss. 5, 2008-09 ,pp. : 523-524

Medical Journals Limited

Access to resources Recommend Favorite

Strategies for optimizing treatment with efalizumab in moderate to severe psoriasis

By Papp Kim Ho Vincent Langley Richard Lynde Charles Poulin Yves Shear Neil Toole John Zip Catherine

Journal of Cutaneous Medicine and Surgery, Vol. 9, Iss. 1, 2005-12 ,pp. : 26-32

Springer Publishing Company

Access to resources Recommend Favorite

Urticaria Associated with Hyper-IgE in a Patient with Psoriasis Undergoing Treatment with Efalizumab

By Saraceno Rosita Scotto Gea Chiricozzi Andrea Chimenti Sergio

Acta Dermato-Venereologica, Vol. 89, Iss. 4, 2009-06 ,pp. : 412-413

Medical Journals Limited

Access to resources Recommend Favorite

Treatment Satisfaction of Patients with Psoriasis

By Schaarschmidt Marthe-Lisa Kromer Christian Herr Raphael Schmieder Astrid Goerdt Sergij Peitsch Wiebke K.

Acta Dermato-Venereologica, Vol. 95, Iss. 5, 2015-05 ,pp. : 572-578

Medical Journals Limited

Access to resources Recommend Favorite

Discontinuation of Methotrexate in Psoriasis

By Due Eva Blomberg Maria Skov Lone Zachariae Claus

Acta Dermato-Venereologica, Vol. 92, Iss. 4, 2012-07 ,pp. : 353-354

Medical Journals Limited

Access to resources Recommend Favorite